Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care centre

Rheumatology (United Kingdom)

Volumn 51, Issue 11, 2012, Pages 2046-2050

  Morin, Marie Paule ^a   Quach, Caroline ^a   Fortin, Élise ^a   Chédeville, Gaëlle ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Immunization; Immunocompromised; Juvenile idiopathic arthritis; Vaccines

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; MEASLES MUMPS RUBELLA VACCINE; VACCINE;

ARTICLE; CHILD; FEMALE; FOLLOW UP; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TERTIARY HEALTH CARE; VACCINATION;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; MALE; QUEBEC; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS; VACCINATION;

EID: 84867755512     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes175     Document Type: Article

References (15)

1. Petty RE, Southwood TR, Manners P et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-2.
2. Cassidy J, Petty R, Laxer R, Lindsley C. Textbook of pediatric rheumatology, 6th edn. Philadelphia, PA: Saunders, 2011.
3. Curtis JR, Patkar N, Xie A et al. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Arthritis Rheum 2007; 56: 1125-33.
4. Gluck T, Muller-Ladner U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis 2008; 46: 1459-65.
5. Kasapcopur O, Cullu F, Kamburoglu-Goksel A et al. Hepatitis B vaccination in children with juvenile idiopathic arthritis. Ann Rheum Dis 2004; 63: 1128-30.
6. Zonneveld-Huijssoon E, Ronaghy A, Van Rossum MA et al. Safety and efficacy of meningococcal C vaccination in juvenile idiopathic arthritis. Arthritis Rheum 2007; 56: 639-46.
7. Dell'era L, Corona F, Daleno C et al. Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis. Vaccine 2012; 30: 936-40.
8. Quartier P, Allantaz F, Cimaz R et al. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann Rheum Dis 2011; 70: 747-54.
9. Heijstek MW, Pileggi GC, Zonneveld-Huijssoon E et al. Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis. Ann Rheum Dis 2007; 66: 1384-7.
10. Borte S, Liebert UG, Borte M, Sack U. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatology 2009; 48: 144-8.
11. Pileggi GS, de Souza CB, Ferriani VP. Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids. Arthritis Care Res (Hoboken) 2010; 62: 1034-9.
12. Boulianne N, Audet D, Ouakki N. Enquête sur la couverture vaccinale des enfants québécois en 2006. Quebec: Institut de santépublique du Québec, 2007.
13. Lima Melo JM, Salviato Pileggi GC, Martins de Carvalho L, Leme Ferriani VP. Immunization status of children with rheumatic diseases: can the pediatric rheumatologist help to improve? (abstract). Pediatric Rheumatology European Society Congress, 2010.
14. Melmed GY, Ippoliti AF, Papadakis KA et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol 2006; 101: 1834-40.
15. Heijstek MW, Ott de Bruin LM, Bijl M et al. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann Rheum Dis 2011; 70: 1704-12.